Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) announces participation in investor conferences and panel discussions on proteomics and genomics.

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences:

• Canaccord 43^rd Annual Growth Conference in Boston, MA
  Management will participate in “The Next Generation of Proteomics from the Research and Clinical Perspectives” Panel on Thursday, August 10^th at 10:00 a.m. Eastern Time
  

• UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA
  Management will host 1x1 investor meetings on Tuesday, August 15^th
  

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

 

FAQ

What conferences is Nautilus Biotechnology participating in?

Nautilus Biotechnology is participating in Canaccord 43rd Annual Growth Conference in Boston and UBS MedTech, Tools and Genomics Summit 2023 in Dana Point.

What panel discussion will Nautilus Biotechnology be part of?

Nautilus Biotechnology's management will participate in 'The Next Generation of Proteomics from the Research and Clinical Perspectives' Panel at the Canaccord conference.

When will the panel discussion take place?

The panel discussion is scheduled for Thursday, August 10th at 10:00 a.m. Eastern Time.

What will Nautilus Biotechnology do at the UBS MedTech, Tools and Genomics Summit 2023?

Nautilus Biotechnology's management will host 1x1 investor meetings on Tuesday, August 15th at the UBS Summit.